# Zinc: a metallic shield against cardiac inflammation

**Authors:** Kemmoy Lattibeaudiere, Shelly McFarlane, Marvin Reid, Irina Korichneva, John H Beattie

PMC · DOI: 10.1093/mtomcs/mfag004 · Metallomics: Integrated Biometal Science · 2026-02-26

## TL;DR

Zinc helps protect the heart from inflammation by regulating immune responses and reducing oxidative stress, suggesting it could be a useful supplement for heart health.

## Contribution

This review highlights zinc's role in modulating cardiac inflammation and proposes it as a promising therapeutic strategy for heart diseases.

## Key findings

- Zinc protects cysteine thiol groups and acts as a redox-sensitive messenger in cellular stress responses.
- Zinc supplementation may reduce myocardial inflammation and cardiac remodeling in oxidative stress-related heart diseases.
- Emerging evidence supports zinc's role in antioxidant defense and cytokine regulation in the cardiovascular system.

## Abstract

Zinc (Zn) is a trace element essential for the function of over 10% of the human proteome, yet the average adult body contains only about two grams. Despite its trace status, Zn plays an indispensable role in immune regulation, inflammation control, and redox signalling. Low Zn status is associated with impaired immune function and increased oxidative stress—factors that critically contribute to the pathogenesis of cardiac inflammatory diseases (CIDs), including myocarditis and pericarditis. These conditions are rising in incidence globally, particularly in younger adults, and are linked to viral infections, autoimmune triggers, and post-vaccination inflammatory responses. Zn not only protects cysteine thiol groups from oxidation but also acts as a redox-sensitive secondary messenger via the “Redox Zinc Switch” mechanism—a key process in modulating cellular responses to oxidative stress. In the cardiovascular system, Zn influences antioxidant defence, cytokine regulation, and membrane repair pathways, including cellular responses that are regulated by protein kinase C and metallothioneins. Emerging evidence supports Zn supplementation as a strategy to mitigate myocardial inflammation, reduce cardiac remodelling, and improve outcomes in oxidative stress driven heart diseases. This review synthesizes current knowledge on Zn’s biochemical, immunological, and therapeutic roles in cardiac inflammation. We argue that maintaining optimal Zn levels through diet or supplementation represents a promising, accessible intervention to reduce the burden of CIDs and improve cardiovascular resilience in at-risk populations.

Graphical AbstractZinc therapy in cardiac inflammation

Zinc therapy in cardiac inflammation

## Linked entities

- **Chemicals:** Zinc (PubChem CID 23994), cysteine (PubChem CID 594)
- **Diseases:** myocarditis (MONDO:0004496), pericarditis (MONDO:0005904)

## Full-text entities

- **Diseases:** pericarditis (MESH:D010493), cardiac inflammation (MESH:D007249), viral infections (MESH:D014777), cardiac remodelling (MESH:D020257), myocarditis (MESH:D009205), CIDs (MESH:D006331)
- **Chemicals:** Zinc (MESH:D015032), thiol (MESH:D013438), cysteine (MESH:D003545)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13017119/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13017119/full.md

## References

147 references — full list in the complete paper: https://tomesphere.com/paper/PMC13017119/full.md

---
Source: https://tomesphere.com/paper/PMC13017119